Kestra Medical Technologies (NASDAQ:KMTS) Stock: Insider Brian Daniel Webster Sells 15,000 Shares

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) insider Brian Webster sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 20th. The shares were sold at an average price of $29.56, for a total value of $443,400.00. Following the completion of the sale, the insider owned 445,215 shares of the company’s stock, valued at $13,160,555.40. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Brian Daniel Webster also recently made the following trade(s):

• On Monday, August 17th, Brian Webster sold 15,000 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $27.48, for a total value of $412,200.00.
• On Tuesday, August 4th, Brian Webster sold 51,900 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $24.52, for a total value of $1,272,588.00.
• On Monday, August 3rd, Brian Webster sold 13,017 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.92, for a total transaction of $311,366.64.
• On Friday, July 31st, Brian Webster sold 8,948 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.60, for a total transaction of $202,224.80.
• On Thursday, July 30th, Brian Webster sold 7,857 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.72, for a total transaction of $178,511.04.

Kestra Medical Technologies Stock Up 1.6%

NASDAQ:KMTS opened at $28.76 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 4.69 and a current ratio of 4.69. Kestra Medical Technologies, Ltd. has a fifty-two week low of $17.34 and a fifty-two week high of $30.00. The company has a fifty day moving average of $26.43 and a two-hundred day moving average of $23.83.

Kestra Medical Technologies (NASDAQ:KMTS) last announced its earnings results on Monday, September 14th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by ($0.14). The company had revenue of $30.97 million during the quarter. Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. On average, equities research analysts forecast that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on KMTS. Piper Sandler reaffirmed an “overweight” rating on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. BTIG Research reissued a “buy” rating and issued a $32.00 target price on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Royal Bank Of Canada set a $30.00 price target on Kestra Medical Technologies in a research report on Tuesday, September 15th. Weiss Ratings raised Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, September 16th. Finally, Oppenheimer initiated coverage on Kestra Medical Technologies in a research report on Tuesday, July 21st. They set a “market perform” rating on the stock. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $29.00.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Sei Investments Co. increased its stake in Kestra Medical Technologies by 22.6% during the first quarter. Sei Investments Co. now owns 237,116 shares of the company’s stock worth $4,726,000 after acquiring an additional 43,753 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of Kestra Medical Technologies by 6.6% in the 1st quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock valued at $1,844,000 after purchasing an additional 5,731 shares during the last quarter. Corient Private Wealth LP lifted its stake in shares of Kestra Medical Technologies by 284.2% in the 2nd quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after purchasing an additional 44,839 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Kestra Medical Technologies by 47.2% during the 1st quarter. Bank of New York Mellon Corp now owns 70,113 shares of the company’s stock worth $1,397,000 after purchasing an additional 22,471 shares during the period. Finally, Spartan Wealth Advisory Services LLC purchased a new position in shares of Kestra Medical Technologies during the 1st quarter worth $603,000.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.